Human endothelin receptor antibody and use thereof
US11712470B2 · kind B2 · utility
0Cited by
19References
9Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Nov 18, 2020 |
| Grant date | Aug 1, 2023 |
| Priority date | — |
| Expiry date | Aug 14, 2041 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2317/92
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention discloses an antibody specifically binding to a human endothelin receptor and uses thereof, where the antibody can inhibit the functions of the human endothelin receptor. The present invention includes the preparation, cloning, expression, and characterization of the antibody. The present invention can be used to effectively treat pulmonary arterial hypertension, a disease associated with pulmonary arterial hypertension, and a reproductive organ cancer in a human.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.